Key Clinical Points Immune Thrombocytopenia Immune thrombocytopenia (ITP) is
diagnosed in patients with a platelet count below 100,000 per cubic millimeter in whom …

Immune thrombocytopenia (ITP) is a complex autoimmune disease characterized by low
platelet counts. The pathogenesis of ITP remains unclear although both antibody-mediated …

Immune thrombocytopenia (ITP) occurs in 2 to 4/100 000 adults and results in variable
bleeding symptoms and thrombocytopenia. In the last decade, changes in our …

Immune thrombocytopenia (ITP) is a rare autoimmune disease due to an abnormal T cell
response, notably supported by splenic T follicular helper cells, that stimulates the …

Immune thrombocytopenia (ITP) is an autoimmune disease defined by low platelet counts
which presents with an increased bleeding risk. Several genetic risk factors (eg …

Thrombocytopenia results from a variety of conditions, including radiation, chemotherapy,
autoimmune disease, bone marrow disorders, pathologic conditions associated with …

Over the past decades, a wealth of information has been reported about the pathogenic
features of immune thrombocytopenia (ITP). To this day, however, it is unclear whether the …

Immune thrombocytopenic purpura (ITP) is an autoimmune condition characterized by low
platelet count with mucocutaneous and other bleedings. Clinical manifestations may range …

Immune thrombocytopenia (ITP) is an autoimmune disorder characterized by antibody-
mediated platelet destruction. The platelet, as an accessible target, has made ITP an …

Background Non-alcoholic fatty liver disease (NAFLD) is a common, chronic liver disease
worldwide. Recent studies have shown that T helper (Th) 17 and regulatory T (Treg) cells …